ZYDUS PHARMS USA INC FDA Approval ANDA 208186

ANDA 208186

ZYDUS PHARMS USA INC

FDA Drug Application

Application #208186

Application Sponsors

ANDA 208186ZYDUS PHARMS USA INC

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002
None (Tentative Approval)003

Application Products

001TABLET;ORALEQ 25MG BASE0SITAGLIPTIN PHOSPHATESITAGLIPTIN PHOSPHATE
002TABLET;ORALEQ 50MG BASE0SITAGLIPTIN PHOSPHATESITAGLIPTIN PHOSPHATE
003TABLET;ORALEQ 100MG BASE0SITAGLIPTIN PHOSPHATESITAGLIPTIN PHOSPHATE

FDA Submissions

UNKNOWN; ORIG1TA2018-09-07STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

ZYDUS PHARMS USA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 208186
            [companyName] => ZYDUS PHARMS USA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"SITAGLIPTIN PHOSPHATE","activeIngredients":"SITAGLIPTIN PHOSPHATE","strength":"EQ 25MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"SITAGLIPTIN PHOSPHATE","activeIngredients":"SITAGLIPTIN PHOSPHATE","strength":"EQ 50MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"SITAGLIPTIN PHOSPHATE","activeIngredients":"SITAGLIPTIN PHOSPHATE","strength":"EQ 100MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/07\/2018","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-09-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.